The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...
The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...
Amid the ongoing controversy over illegal medical practices by so-called “injection aunt,” a scene of Jun Hyun-moo appearing ...
For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole while a clear bag slowly empties into a vein. A new generation of ...
LOWELL — The City Council voted Tuesday evening to prohibit safe injection sites within the city ahead of proposed bills in the Legislature that would allow such facilities in Massachusetts.
Cosentyx (secukinumab) comes as a subcutaneous injection under the skin or an intravenous (IV) infusion into a vein. Doctors may prescribe it to treat plaque psoriasis, psoriatic arthritis, and other ...
The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...
Our city is at a breaking point in the addiction crisis. Residents are living with the daily consequences of unchecked drug use: families finding needles in their yards and parks, people sleeping in ...
Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Now Available at over 50 iCRYO Clinics and More than 900 Total Clinics Nationwide Niagen IV and injections perfectly align ...
A used needle is seen on the ground on Friday, March 22, 2024, in Baker Park in Grants Pass, Ore. The two candidates vying to represent District 7 on Boston City Council have different opinions about ...
The Boston City Council struck down a resolution opposing safe injection sites, with proponents rejecting notions that legalizing such centers would incentivize addicts to shoot up and saying that ...